Medicines in Development for Leukemia & Lymphoma 2015 Report

America’s biopharmaceutical research companies are developing more than 240 medicines for leukemia, lymphoma and other blood cancers.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.